Show simple item record

dc.contributor.authorFarias, Jorge G
dc.contributor.authorCarrasco-Pozo, Catalina
dc.contributor.authorCarrasco Loza, Rodrigo
dc.contributor.authorSepulveda, Nestor
dc.contributor.authorAlvarez, Pedro
dc.contributor.authorQuezada, Mauricio
dc.contributor.authorQuinones, John
dc.contributor.authorMolina, Victor
dc.contributor.authorCastillo, Rodrigo L
dc.date.accessioned2019-12-05T01:36:52Z
dc.date.available2019-12-05T01:36:52Z
dc.date.issued2017
dc.identifier.issn1535-3702
dc.identifier.doi10.1177/1535370216649263
dc.identifier.urihttp://hdl.handle.net/10072/389512
dc.description.abstractThe mechanistic evidence to support the cardioprotective effects of polyunsaturated fatty acids (PUFA) are controversial. The aim was to test cardioprotective mechanisms induced by PUFA supplementation against cardiac ischemia-reperfusion (IR) injury. Ten-week-old male Wistar rats (225 ± 14 g, n = 14) were divided in two groups: rats without supplementation (n = 7) and a PUFA group, supplemented by PUFA (0.6 g/kg/day; DHA:EPA = 3:1) for eight weeks (n = 7). Hearts were perfused with Krebs–Henseleit buffer for 20 min (control conditions); others were subjected to control conditions, 30 min of global ischemia and 120 min of reperfusion (IR group). Infarct size (IS) and left ventricular developed pressure (LVDP) were measured at 120 min of reperfusion. Oxidative stress biomarkers (TBARS, total carbonyls), antioxidant status (CAT, catalase; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase activity and GSH/GSSG ratio), myeloperoxidase activity, ATP levels and nuclear transcription factor erythroid 2-related factor 2 (Nrf2) and nuclear factor kappaB (NF-κB) were determined in both experimental conditions. At the end of reperfusion, hearts supplemented with PUFA showed lower IS and a higher LVDP compared with the nonsupplemented rats. Hearts in the group supplemented with PUFA showed lower levels of oxidative stress markers and higher antioxidant activity, decreased MPO activity and NF-κB and Nrf2 activation compared with the nonsupplemented group. Cardioprotective effects of PUFA are exerted through induction of anti-inflammatory and antioxidant mechanism at tissue level.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherSage Publications
dc.relation.ispartofpagefrom1104
dc.relation.ispartofpageto1114
dc.relation.ispartofissue10
dc.relation.ispartofjournalExperimental Biology and Medicine
dc.relation.ispartofvolume242
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode11
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsMedicine, Research & Experimental
dc.subject.keywordsResearch & Experimental Medicine
dc.subject.keywordsPolyunsaturated fatty acids
dc.titlePolyunsaturated fatty acid induces cardioprotection against ischemia-reperfusion through the inhibition of NF-kappaB and induction of Nrf2
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationFarias, JG; Carrasco-Pozo, C; Carrasco Loza, R; Sepulveda, N; Alvarez, P; Quezada, M; Quinones, J; Molina, V; Castillo, RL, Polyunsaturated fatty acid induces cardioprotection against ischemia-reperfusion through the inhibition of NF-kappaB and induction of Nrf2, Experimental Biology and Medicine, 2017, 242 (10), pp. 1104-1114
dc.date.updated2019-12-05T00:29:58Z
gro.hasfulltextNo Full Text
gro.griffith.authorCarrasco Pozo, Catalina A.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record